TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $214K of Entrada Therapeutics, Inc.
Sold$214,379
$13.01Price
16,477Shares
−12%Stake
What TRDA did after the filing
- The stock from Wed, Mar 11 close, $13.50
- −5.1%
- S&P 500, same days
- +4.7%
Measured over 30 trading days, to the Apr 23 close.
Traded Mon, Mar 9. Filed Wed, Mar 11, 12:34 PM ET, during the session. Returns use the Mar 11 close and the Apr 23 close. Not investment advice.